logo

For the Inventor, By the Inventor

Oss, Netherlands

N.v. Organon


USPTO Granted Patents = 101

% Expired Patents = 50.5



Trademarks = 74

Forward Citations = 346

Loading Chart...
Loading Chart...

198 inventors (with patents filed for the assignee):

goldMedal Cornelis Marius Timmers (10 out of 18 patents)

silverMedal Hubert Jan Jozef Loozen (8 out of 18 patents)

bronzeMedal Simon James Anthony Grove (6 out of 10 patents)

4.  Neeltje Miranda Teerhuis (6 out of 7 patents)

5.  Julia Adam-Worrall (6 out of 6 patents)

6.  Zoran Rankovic (6 out of 6 patents)

7.  Susan Elizabeth Napier (6 out of 6 patents)

8.  Gerrit Herman Veeneman (5 out of 10 patents)

9.  Jiaqiang Cai (5 out of 6 patents)

10.  Gerardus Johannes Kemperman (5 out of 8 patents)

11.  John Richard Morphy (5 out of 8 patents)

12.  Pedro Harold Han Hermkens (4 out of 8 patents)

13.  Willem Frederik Johan Karstens (4 out of 9 patents)

14.  Herman Thijs Stock (4 out of 6 patents)

15.  Jaap Van Der Louw (4 out of 17 patents)


Core Competencies:
Pharmaceutical Compounds
Progesterone Receptor Modulators
Androgens
Tetrahydroquinoline Derivatives
Indole Derivatives
Estrogenic Compounds
Peptide Synthesis
Glycine Transport Inhibitors
Opioid Analgesics
Cannabinoid Receptor Agonists
Steroid Compounds
Vasopressin Antagonists

101 patents:

1. 8563694 - Fully human antibodies to BTLA (2013-10-22),
2. 8124647 - Non-steroidal androgens compounds (2012-02-28),
3. 8124372 - Selective enzymatic amidation of C-terminal esters or acids of peptides (2012-02-28),
4. 8106007 - Conjugates of a polypeptide and a pentasaccharide (2012-01-31),
5. 8071589 - Dihydrobenzoindazoles (2011-12-06),
6. 8071587 - (Dihydro)imidazoiso[5,1-A]quinolines (2011-12-06),
7. 8063102 - Tetrahydronaphthalen-2-ol derivatives (2011-11-22),
8. 8063037 - Progesterone receptor modulators (2011-11-22),
9. 8058441 - Tetrahydroquinoline derivatives (2011-11-15),
10. 8058436 - Method for the preparation of enantiomerically pure mirtazapine (2011-11-15),
11. D647295 - Slide case tablet dispenser (2011-10-25),
12. 8034945 - 4-phenyl-5-OXO-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility (2011-10-11),
13. 8034804 - (Pyrido/thieno)-[f]-oxazepine-5-one derivatives (2011-10-11),
14. D645658 - Slide case tablet dispenser (2011-09-27),
15. 8026236 - 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives (2011-09-27),
Company Overview
N.v. Organon is a pharmaceutical company based in Oss, Netherlands, specializing in the development and manufacturing of innovative therapeutic compounds. The organization focuses on a range of core technology topics, including progesterone receptor modulators, androgens, and various derivatives such as tetrahydroquinoline and indole. Additionally, Organon is engaged in peptide synthesis and the exploration of glycine transport inhibitors, positioning itself as a key player in the pharmaceutical landscape with a commitment to advancing healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

N.v. Organon USPTO Patent Assignee Logo
101 Patents

#1 in Oss

#85 in Netherlands

#7,717 in the World

Oss, NL
Oss, Netherlands

N.v. Organon

Forward Citations = 346

198 inventors:

goldMedal Cornelis Marius Timmers (10 out of 18 patents)

silverMedal Hubert Jan Jozef Loozen (8 out of 18 patents)

bronzeMedal Simon James Anthony Grove (6 out of 10 patents)

4.  Neeltje Miranda Teerhuis (6 out of 7 patents)

5.  Julia Adam-Worrall (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: N.v. Organon. Retrieved from https://idiyas.com/company/n-v-organon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…